|
ARL6IP6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.46230000000569E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.834700E-04 |
| Normal-vs-Stage2 |
2.322000E-02 |
| Normal-vs-Stage3 |
1.428300E-02 |
| Normal-vs-Stage4 |
1.151800E-02 |
| Stage1-vs-Stage2 |
5.626800E-01 |
| Stage1-vs-Stage3 |
5.768600E-01 |
| Stage1-vs-Stage4 |
3.721900E-02 |
| Stage2-vs-Stage3 |
9.416200E-01 |
| Stage2-vs-Stage4 |
1.788960E-01 |
| Stage3-vs-Stage4 |
1.464650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.07899999999928E-05 |
| Normal-vs-AfricanAmerican |
3.763600E-03 |
| Normal-vs-Asian |
1.633190E-01 |
| Caucasian-vs-AfricanAmerican |
6.526400E-01 |
| Caucasian-vs-Asian |
6.880000E-01 |
| AfricanAmerican-vs-Asian |
5.594000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.04870000000335E-05 |
| Normal-vs-Female |
6.04899999999686E-05 |
| Male-vs-Female |
1.824640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.498000E-02 |
| Normal-vs-Extreme_Weight |
4.805000E-03 |
| Normal-vs-Obese |
2.215900E-04 |
| Normal-vs-Extreme_Obese |
3.288800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.159800E-01 |
| Normal_Weight-vs-Obese |
1.231780E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.106600E-01 |
| Extreme_Weight-vs-Obese |
1.398390E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.502600E-01 |
| Obese-vs-Extreme_Obese |
3.398600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.261900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.45210000002116E-06 |
| Normal-vs-Age(61-80Yrs) |
1.716440E-03 |
| Normal-vs-Age(81-100Yrs) |
4.980400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.628300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.211800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.467800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.279900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.413010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.084000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.29489999950638E-07 |
| Normal-VS-Type2 PRCC |
5.265400E-01 |
| Normal-VS-KIRP CIMP |
3.023900E-03 |
| Normal-VS-Unclassified PRCC |
1.855260E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.695530000001E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.346100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.207800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.981200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.543000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.000300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.136100E-02 |
| Normal-vs-N1 |
3.740900E-03 |
| Normal-vs-N2 |
9.753800E-04 |
| N0-vs-N1 |
2.910400E-02 |
| N0-vs-N2 |
8.574000E-02 |
| N1-vs-N2 |
9.175800E-01 |
|
|
